A search for multidrug resistance modulators: The effects of retinoids in human colon carcinoma cells

In Vivo

Volumn 20, Issue 6 A, 2006, Pages 729-734

  Bartolini, G ^a   Orlandi, M ^a   Papi, A ^a   Ammar, K ^a   Guerra, F ^a   Ferreri, Anna Maria ^a,b   Rocchi, P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Sezione Cancerologia   (Italy)

Author keywords

Colon carcinoma; Multidrug resistance; Retinoids

Indexed keywords

6HYDROXY 11 O HYDROXYPHENANTHRENE; ANTINEOPLASTIC AGENT; DNA; GLYCOPROTEIN P; LIPOCORTIN 5; RETINOIC ACID; RETINOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOASSAY; CARCINOMA CELL; CELL PROLIFERATION; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TRANSPORT; FRAGMENTATION REACTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PROTEIN SYNTHESIS INHIBITION;

EID: 33846077187     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Lazaris AC, Kavantzas NG, Zorzos HS, Tsavaris NV and Davaris PS: Markers of drug resistance in relapsing colon cancer. J Cancer Res Clin Oncol 128: 114-118, 2002.
2. Shen LZ, Hua YB, Yu Xm, Xu Q, Chen T, Wang JH and Wu WX: Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo. World J Gastroenterol 11: 1060-1064, 2005.
3. Hinoshita E, Uchiumi T, Taguchi K, Kinukawa N, Tsumeyoshi M, Maehara Y, Sugimachi K and Kuwano M: Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res 6: 2401-2407, 2000.
4. Zorzos HS, Lazaris AC, Korkolopoulou PA, Kavantzas NG, Tseleni-Balafouta S, Patsouris ES, Tsavaris NV and Davaris PS: Multidrug resistance proteins and topoisomerase II alpha expression in colon cancer: association with metastatic potential. Pathology 35: 315-318, 2003.
5. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
6. Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogan TM, Saclarides TJ, Roninson JB and Coon JS: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720-2726, 1991.
7. Sporn MB, Dunlop NM, Newton DL and Smith JM: Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35: 1332-1338, 1976.
8. Zanardi S, Serrano D, Argusti A, Barile M, Puntoni M and Decensi A: Clinical trials with retinoids for breast cancer chemoprevention. Endocr Relat Cancer 13: 51-68, 2006.
9. Dragnev KH, Petty WJ, Shah S, Biddle A, Desal NB, Memoli V, Rigas JR and Dmitrovsky E: Bexarotene and erlotinib for aerodigestive tract cancer. J Clin Oncol 23: 8757-8764, 2005.
10. Abu J, Batuwangala M, Herbert K and Symonds P: Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer. Lancet Oncol 6: 712-720, 2005.
11. Otley CC, Stasko T, Tope WD and Lebwohl M: chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effect. Dermatol Surg 32: 562-568, 2006.
12. Ocker M, Herold C, Ganslmayer M, Hahn EG and Schuppan D: The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro. Int J Cancer 107: 453-459, 2003.
13. Bartolini G, Ammar K, Mantovani B, Scannabissi F, Ferreri AM, Rocchi P and Orlandi M: Retinoids and cancer: antitumoral effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29. Anticancer Res 24: 1779-1784, 2004.
14. Gottesman MM and Ling V: The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580: 998-1009, 2006.
15. Goldstein LJ: Clinical reversal of drug resistance. Curr Probl Cancer 19: 65-124, 1995.
16. Meschini S, Calcabrini A, Monti E, Del Bufalo D, Stringaro A, Dolfini E and Arancia G: Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human adenocarcinoma cells. Int J Cancer 87: 615-628, 2000.
17. Kartner N, Riordan JR and Ling V: Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221: 1285-1288, 1983.
18. Pauwels R, Balzarini J, Baba M, Snoeck R and Schols D: Rapid and automated tetrazolium - based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20: 390-391, 1988.
19. Lowry DH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
20. Pasetto LM, D'Andrea MR, Jirillo A, Rossi E and Monfardini S: Stable disease in advanced colorectal cancer: therapeutic implications. Anticancer Res 26: 511-522, 2006.
21. Ragnhammar P, Hafstrom L, Nygren P and Glimelius B: SBV-group. Swedish Council of Technology Assessment in Health Care: A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 40: 282-308, 2001.
22. Fanciulli M, Bruno T, Giovannelli A, Gentile FP, Di Padova M, Rubiu O and Floridi A: Energy metabolism of human LoVo colon carcinoma cells: correlation to drug resistance and influence of Lonidamine. Clin Cancer Res 6: 1590-1597, 2000.
23. Linn Sc and Giaccone G: MDR1/P-glycoprotein expression in colorectal cancer. Eur J Cancer 31: 1291-1294, 1995.
24. Bollog W and Matter A: From vitamin A to retinoids in experimental and clinical ontology: achievements, failures, and outlook. Ann NY Acad Sci 359: 9-23, 1981.
25. Um SJ, Han HS, Kwon YJ, Park SH, Rho YS, Sin HS and Park JS: Novel retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cell. Int J Cancer 107: 1038-1046, 2003.
26. Orlandi M, Mantovani B, Ammar K, Dal Monte P and Bartolini G: Retinoids and cancer: antitumoral effects of ATRA, 9-cis RA and the new retinoid IIF on the HL60 leukemic cell line. Med Princ Pract 12: 164-169, 2003.
27. Bartolini G, Orlandi M, Ammar K, Magrini E, Ferreri AM and Rocchi P: Effect of a new derivative of retinoic acid on proliferation and differentiation in human neuroblastoma cells. Anticancer Res 23: 1495-1499, 2003.
28. Paulsen JE and Lutzow-Holm C: In vivo growth inhibition of human colon carcinoma cells (HT29) by all-trans-retinoic acid, difluoromethylornithine, and colon mitosis inhibitor, individually and in combination. Anticancer Res 20: 3485-3489, 2000.
29. Nakagawa K, Sogo S, Hioki K, Tokunaga R and Taketani S: Acquisition of cell adhesion and induction of focal adhesion kinase of human colon cancer Colo201 cells by retinoic acid-induced differentiation. Differentiation 62: 249-257, 1998.
30. Suzui M, Sunagawa N, Chiba I, Moriwaki H and Yoshimi N: Acyclic retinoid, a novel synthetic retinoid, induces growth inhibition, apoptosis, and changes in mRNA expression of cell cycle- and differentiation-related molecules in human colon carcinoma cells, Int J Oncol 28: 1193-1199, 2006.
31. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR and Jones RJ: Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55: 1811-1816, 1995.
32. Kikuchi Y, Dinjens WN and Bosman FT: Proliferation and apoptosis in proliferative lesions of the colon and rectum. Wirchows Arch 431: 111-117, 1997.
33. Lee MO, Han SY, Jiang S, Park JH and Kim SJ: Differential effects of retinoic acid on growth and apoptosis in human colon cancer cells lines associated with the induction of retinoic acid receptor beta, Biochem Pharmacology 59: 485-496, 2000.
34. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC and Zhang XK: Retinoic acid receptor mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 16: 1138-1149, 1996.
35. Bruel G, Benoit G, De Nay D, Brown S and Lanotte M: Distinct apoptotic responses in maturation sensitive and resistant t (15;17) acute promyelocytic leukemia N84 cells. 9-cis retinoic acid induces apoptosis indipendent of maturation and Bcl-2 expression. Leukemia 9: 1173-1184, 1995.
36. Pietrafita J and Pfahl M: Retinoid induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol Cell Biol 17: 6348-6358, 1997.
37. Villani MG, Appierto V, Cavadini E, Lettiga A, Prinetti A, Clagett-Dame M, Curley RW and Formelli F: 4-Oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Cancer Res 66: 3238-3247, 2006.
38. Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000.
39. Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. Cal Cancer J Clin 55: 178-194, 2005.